Stockreport

Madrigal Pharmaceuticals: What To Expect With Q4 Earnings Coming Thursday [Seeking Alpha]

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com
PDF Rezdiffra's rapid commercialization and first-mover advantage in the MASH market underpin robust sales growth, with Q3 net sales at $287.3M and 29,500 active patients. [Read more]